US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

bluebird bio

4.97

0.0000

Volume:- -

Turnover:6.02M

Market Cap:48.67M

PE:-0.24

High:4.97

Open:4.97

Low:4.97

Close:4.97

52wk High:28.60

52wk Low:3.20

Shares:9.79M

Float Shares:9.73M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-20.5905

EPS(LYR):-24.8442

ROE:-546.54%

ROA:-28.37%

PB:-0.84

PE(LYR):-0.20

Loading ...

Overview Company News Filings

Press Release: bluebird bio Announces Completion of Acquisition by Carlyle and SK Capital

Press Release: Carlyle and SK Capital Partners Announce Expiration of bluebird bio Tender Offer

Gene Therapy Death Worsens Picture for an Already Troubled Field -- Barrons.com

Bluebird Bio Urges Stockholders to Tender Shares as Carlyle and SK Capital Acquisition Deadline Approaches

BRIEF-Carlyle, SK Capital Partners And Bluebird Bio Provide Updated Tender Instructions

Press Release: Carlyle, SK Capital Partners and bluebird bio Provide Updated Tender Instructions

Deals of the day-Mergers and acquisitions

BUZZ-U.S. STOCKS ON THE MOVE-Robinhood, Oklo, Chimera Investment

Bluebird bio, Carlyle, SK Capital Revise Acquisition Deal to Add New Cash Option

MT Newswires Live

BUZZ- bluebird bio soars on revised offer from Carlyle, SK Capital Partners

Bluebird bio receives higher upfront offer from PE firms Carlyle, SK Capital

BRIEF-Carlyle says Bluebird stockholders can elect $3 per share plus cvr or $5 per share

Press Release: Carlyle, SK Capital Partners and bluebird bio Amend Merger Agreement

Press Release: Important Information for bluebird bio Stockholders to Tender Shares for Acquisition by Carlyle and SK Capital

Bluebird bio, Carlyle-SK Deal Clears Regulatory Hurdles

MT Newswires Live

BRIEF-Carlyle And Sk Capital Receive All Required Regulatory Approvals To Complete The Acquisition Of Bluebird Bio

bluebird bio Inc expected to post a loss of $3.69 a share - Earnings Preview

US Health Secretary Reportedly Says 35 States to Join Pilot Program for Sickle Cell Disease Gene Therapies

MT Newswires Live

BUZZ-U.S. STOCKS ON THE MOVE-Grocery Outlet, Abbott, General Dynamics

Bluebird Bio Reaffirms Support for Carlyle Deal Amid Lack of Binding Offer From Ayrmid

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BLUE/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BLUE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BLUE\",,,,,undefined,":{"symbol":"BLUE","market":"US","secType":"STK","nameCN":"bluebird bio","latestPrice":4.97,"timestamp":1748635200000,"preClose":4.97,"halted":3,"volume":0,"delay":0,"floatShares":9726014,"shares":9792458,"eps":-20.59049,"marketStatus":"Halted","change":0,"latestTime":"10-17 08:55:44 EDT","open":4.97,"high":4.97,"low":4.97,"amount":6020349.790823201,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-20.59049,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1760707800000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1371614400000,"exchange":"NASDAQ","adjPreClose":4.97,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BLUE\",,,,,undefined,":{"symbol":"BLUE","floatShares":9726014,"roa":"-28.37%","roe":"-546.54%","lyrEps":-24.844153,"shares":9792458,"dividePrice":0,"high":4.97,"amplitude":0,"preClose":4.97,"low":4.97,"week52Low":3.2,"pbRate":"-0.84","psRate":"0.47","week52High":28.6,"institutionHeld":0,"latestPrice":4.97,"eps":-20.59049,"divideRate":0,"volume":0,"delay":0,"ttmEps":-20.59049,"open":4.97,"prevYearClose":8.34,"prevWeekClose":4.97,"prevMonthClose":4.97,"prevQuarterClose":4.88},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BLUE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-06-03","symbol":"BLUE","reason":null,"defaultRemindTime":1748957400000,"announcedDate":"2025-05-12","type":"delisting","dateTimestamp":1748923200000},{"market":"US","date":"2025-05-14","symbol":"BLUE","fiscalQuarterEnding":"2025/03","expectedEps":-3.6,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"post","actualEps":-2.66},{"market":"US","date":"2025-03-27","symbol":"BLUE","fiscalQuarterEnding":"2024/12","expectedEps":-6.6,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"post","actualEps":-23.74},{"market":"US","date":"2024-12-13","symbol":"BLUE","defaultRemindTime":1734100200000,"type":"split","dateTimestamp":1734066000000,"forFactor":20,"toFactor":1,"ratio":20},{"market":"US","date":"2024-11-14","symbol":"BLUE","fiscalQuarterEnding":"2024/09","expectedEps":-0.38,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"pre","actualEps":-0.31}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BLUE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BLUE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.25,"hold":0.75,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.75,"analysts":4,"updateTime":1740628800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BLUE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BLUE","date":"2025-05-30","current":-0.241374,"percent":0.930251,"low":-6.665306,"twenty":-3.642262,"median":-1.780463,"eighty":-0.422755,"high":-0.124089,"avg":-2.230498,"sd":1.722825,"marketCap":48668516},"quantilePoints":[{"date":"2020-10-16","current":-5.685323,"twenty":-29.004542,"median":-18.806807,"eighty":-7.478825,"marketCap":3715108336},{"date":"2020-10-23","current":-5.627558,"twenty":-28.898342,"median":-18.714944,"eighty":-7.358061,"marketCap":3677361246},{"date":"2020-10-30","current":-5.240429,"twenty":-28.718134,"median":-18.624119,"eighty":-7.254688,"marketCap":3424389520},{"date":"2020-11-06","current":-4.743107,"twenty":-28.588548,"median":-18.516559,"eighty":-7.119935,"marketCap":3045871654},{"date":"2020-11-13","current":-4.75551,"twenty":-28.330304,"median":-18.375906,"eighty":-7.062006,"marketCap":3053836453},{"date":"2020-11-20","current":-4.451637,"twenty":-28.139674,"median":-18.28425,"eighty":-6.998333,"marketCap":2858698892},{"date":"2020-11-27","current":-4.553962,"twenty":-28.094881,"median":-18.227591,"eighty":-6.955943,"marketCap":2924408479},{"date":"2020-12-04","current":-4.849566,"twenty":-27.99058,"median":-18.098562,"eighty":-6.937065,"marketCap":3114236174},{"date":"2020-12-11","current":-4.388589,"twenty":-27.746937,"median":-18.027082,"eighty":-6.835555,"marketCap":2818211167},{"date":"2020-12-18","current":-4.622178,"twenty":-27.49438,"median":-17.952751,"eighty":-6.745535,"marketCap":2968214870},{"date":"2020-12-24","current":-4.706932,"twenty":-27.318834,"median":-17.662599,"eighty":-6.678002,"marketCap":3022640992},{"date":"2020-12-31","current":-4.472309,"twenty":-27.047329,"median":-17.565696,"eighty":-6.50032,"marketCap":2871973556},{"date":"2021-01-08","current":-5.017006,"twenty":-26.829112,"median":-17.3374,"eighty":-6.40904,"marketCap":3221760952},{"date":"2021-01-15","current":-5.222689,"twenty":-26.730208,"median":-17.184049,"eighty":-6.30554,"marketCap":3353843859},{"date":"2021-01-22","current":-4.820626,"twenty":-26.582381,"median":-17.060733,"eighty":-6.26485,"marketCap":3095651644},{"date":"2021-01-29","current":-4.604607,"twenty":-26.243871,"median":-16.939087,"eighty":-6.212173,"marketCap":2956931406},{"date":"2021-02-05","current":-4.930186,"twenty":-26.07498,"median":-16.787084,"eighty":-6.160266,"marketCap":3166007364},{"date":"2021-02-12","current":-4.729671,"twenty":-25.973266,"median":-16.672604,"eighty":-6.029064,"marketCap":3037243123},{"date":"2021-02-19","current":-2.757596,"twenty":-25.925047,"median":-16.611132,"eighty":-5.994823,"marketCap":1770840177},{"date":"2021-02-26","current":-3.374985,"twenty":-25.801094,"median":-16.50611,"eighty":-5.923812,"marketCap":2088086468},{"date":"2021-03-05","current":-3.112366,"twenty":-25.657929,"median":-16.351143,"eighty":-5.845241,"marketCap":1925605141},{"date":"2021-03-12","current":-3.519317,"twenty":-25.482083,"median":-16.253819,"eighty":-5.801337,"marketCap":2177384056},{"date":"2021-03-19","current":-3.427075,"twenty":-25.390636,"median":-16.128577,"eighty":-5.751196,"marketCap":2120314169},{"date":"2021-03-26","current":-3.253442,"twenty":-25.346674,"median":-15.994382,"eighty":-5.716131,"marketCap":2012888499},{"date":"2021-04-01","current":-3.259954,"twenty":-25.119599,"median":-15.831378,"eighty":-5.70438,"marketCap":2016916961},{"date":"2021-04-09","current":-3.055935,"twenty":-24.916554,"median":-15.562584,"eighty":-5.668905,"marketCap":1890691799},{"date":"2021-04-16","current":-3.068958,"twenty":-24.828569,"median":-15.461268,"eighty":-5.646597,"marketCap":1898748724},{"date":"2021-04-23","current":-3.10911,"twenty":-24.735617,"median":-15.35122,"eighty":-5.618622,"marketCap":1923590910},{"date":"2021-04-30","current":-3.270475,"twenty":-24.632445,"median":-15.189025,"eighty":-5.555216,"marketCap":2023426440},{"date":"2021-05-07","current":-3.305721,"twenty":-24.564694,"median":-15.112872,"eighty":-5.516689,"marketCap":2055801263},{"date":"2021-05-14","current":-3.288368,"twenty":-24.564694,"median":-14.990236,"eighty":-5.436628,"marketCap":2045009655},{"date":"2021-05-21","current":-3.421768,"twenty":-24.564694,"median":-14.68786,"eighty":-5.385754,"marketCap":2127970139},{"date":"2021-05-28","current":-3.375132,"twenty":-24.461341,"median":-14.461122,"eighty":-5.333918,"marketCap":2098967693},{"date":"2021-06-04","current":-3.353441,"twenty":-24.39724,"median":-14.291015,"eighty":-5.233602,"marketCap":2085478184},{"date":"2021-06-11","current":-3.698329,"twenty":-24.239772,"median":-14.160426,"eighty":-5.21052,"marketCap":2299961386},{"date":"2021-06-18","current":-3.595297,"twenty":-24.239772,"median":-14.086293,"eighty":-5.176482,"marketCap":2235886216},{"date":"2021-06-25","current":-3.352357,"twenty":-24.233772,"median":-13.991278,"eighty":-5.14281,"marketCap":2084803708},{"date":"2021-07-02","current":-3.402246,"twenty":-24.190419,"median":-13.902228,"eighty":-5.116437,"marketCap":2115829580},{"date":"2021-07-09","current":-3.315482,"twenty":-24.09118,"median":-13.826306,"eighty":-5.095966,"marketCap":2061871542},{"date":"2021-07-16","current":-2.904436,"twenty":-24.019083,"median":-13.732819,"eighty":-5.061339,"marketCap":1806245335},{"date":"2021-07-23","current":-2.817671,"twenty":-23.908048,"median":-13.588288,"eighty":-5.025843,"marketCap":1752287297},{"date":"2021-07-30","current":-2.755852,"twenty":-23.741468,"median":-13.42305,"eighty":-5.003005,"marketCap":1713842194},{"date":"2021-08-06","current":-2.714639,"twenty":-23.709864,"median":-13.208184,"eighty":-4.974177,"marketCap":1688212126},{"date":"2021-08-13","current":-1.482167,"twenty":-23.709864,"median":-13.087065,"eighty":-4.93621,"marketCap":1248175800},{"date":"2021-08-20","current":-1.411549,"twenty":-23.709864,"median":-12.935961,"eighty":-4.885525,"marketCap":1188706676},{"date":"2021-08-27","current":-1.454883,"twenty":-23.709864,"median":-12.819769,"eighty":-4.846258,"marketCap":1225199093},{"date":"2021-09-03","current":-1.444451,"twenty":-23.709864,"median":-12.744198,"eighty":-4.814631,"marketCap":1216413882},{"date":"2021-09-10","current":-1.434821,"twenty":-23.709864,"median":-12.706838,"eighty":-4.800778,"marketCap":1208304456},{"date":"2021-09-17","current":-1.47013,"twenty":-23.709864,"median":-12.501311,"eighty":-4.784672,"marketCap":1238039017},{"date":"2021-09-24","current":-1.47976,"twenty":-23.664121,"median":-12.447794,"eighty":-4.762606,"marketCap":1246148443},{"date":"2021-10-01","current":-1.53513,"twenty":-23.654866,"median":-12.20478,"eighty":-4.748028,"marketCap":1292777642},{"date":"2021-10-08","current":-1.532723,"twenty":-23.622718,"median":-12.163015,"eighty":-4.729257,"marketCap":1290750285},{"date":"2021-10-15","current":-1.677168,"twenty":-23.601075,"median":-12.087214,"eighty":-4.702255,"marketCap":1412391674},{"date":"2021-10-22","current":-1.669143,"twenty":-23.601075,"median":-11.997916,"eighty":-4.657667,"marketCap":1405633819},{"date":"2021-10-29","current":-1.878588,"twenty":-23.601075,"median":-11.865439,"eighty":-4.624658,"marketCap":1582013832},{"date":"2021-11-05","current":-1.065968,"twenty":-23.601075,"median":-11.694482,"eighty":-4.593444,"marketCap":921209435},{"date":"2021-11-12","current":-0.947527,"twenty":-23.601075,"median":-11.590604,"eighty":-4.558716,"marketCap":818852831},{"date":"2021-11-19","current":-0.868026,"twenty":-23.601075,"median":-11.391049,"eighty":-4.50606,"marketCap":750147714},{"date":"2021-11-26","current":-0.851801,"twenty":-23.601075,"median":-11.342755,"eighty":-4.434743,"marketCap":736126261},{"date":"2021-12-03","current":-0.807183,"twenty":-23.601075,"median":-11.195139,"eighty":-4.367086,"marketCap":697567266},{"date":"2021-12-10","current":-0.72687,"twenty":-23.601075,"median":-11.117686,"eighty":-4.124342,"marketCap":628161076},{"date":"2021-12-17","current":-0.861536,"twenty":-23.601075,"median":-10.927243,"eighty":-3.946725,"marketCap":744539133},{"date":"2021-12-23","current":-0.924812,"twenty":-23.601075,"median":-10.905374,"eighty":-3.86272,"marketCap":799222798},{"date":"2021-12-31","current":-0.810428,"twenty":-23.601075,"median":-10.794206,"eighty":-3.796707,"marketCap":700371557},{"date":"2022-01-07","current":-0.774733,"twenty":-23.600422,"median":-10.712197,"eighty":-3.667745,"marketCap":669524361},{"date":"2022-01-14","current":-0.708212,"twenty":-23.600422,"median":-10.605981,"eighty":-3.59171,"marketCap":612036405},{"date":"2022-01-21","current":-0.587337,"twenty":-23.600422,"median":-10.408884,"eighty":-3.560157,"marketCap":507576584},{"date":"2022-01-28","current":-0.610863,"twenty":-23.600422,"median":-10.239531,"eighty":-3.523658,"marketCap":527907690},{"date":"2022-02-04","current":-0.552454,"twenty":-23.600422,"median":-10.137056,"eighty":-3.50114,"marketCap":477430461},{"date":"2022-02-11","current":-0.532984,"twenty":-23.600422,"median":-9.913896,"eighty":-3.439836,"marketCap":460604717},{"date":"2022-02-18","current":-0.497289,"twenty":-23.600422,"median":-9.393558,"eighty":-3.417864,"marketCap":429757522},{"date":"2022-02-25","current":-0.500534,"twenty":-23.563038,"median":-9.01256,"eighty":-3.375132,"marketCap":432561812},{"date":"2022-03-04","current":-0.435899,"twenty":-23.380694,"median":-8.88636,"eighty":-3.370458,"marketCap":357166375},{"date":"2022-03-11","current":-0.381848,"twenty":-23.26024,"median":-8.712464,"eighty":-3.356786,"marketCap":312877744},{"date":"2022-03-18","current":-0.435028,"twenty":-23.13424,"median":-8.502693,"eighty":-3.335534,"marketCap":356452042},{"date":"2022-03-25","current":-0.434156,"twenty":-22.929769,"median":-8.170099,"eighty":-3.318084,"marketCap":355737709},{"date":"2022-04-01","current":-0.432412,"twenty":-22.753924,"median":-7.715947,"eighty":-3.299826,"marketCap":354309044},{"date":"2022-04-08","current":-0.411489,"twenty":-22.62377,"median":-7.548744,"eighty":-3.278908,"marketCap":337165058},{"date":"2022-04-14","current":-0.395797,"twenty":-22.472015,"median":-7.491824,"eighty":-3.270387,"marketCap":324307068},{"date":"2022-04-22","current":-0.340002,"twenty":-22.175125,"median":-7.385324,"eighty":-3.259878,"marketCap":278589772},{"date":"2022-04-29","current":-0.316463,"twenty":-21.908875,"median":-7.266844,"eighty":-3.2426,"marketCap":259302788},{"date":"2022-05-06","current":-0.325243,"twenty":-21.880488,"median":-7.181743,"eighty":-3.226541,"marketCap":266496929},{"date":"2022-05-13","current":-0.34672,"twenty":-21.880488,"median":-7.083424,"eighty":-3.199384,"marketCap":255089826},{"date":"2022-05-20","current":-0.317584,"twenty":-21.880488,"median":-7.010709,"eighty":-3.176659,"marketCap":233653706},{"date":"2022-05-27","current":-0.318555,"twenty":-21.880488,"median":-6.959269,"eighty":-3.111715,"marketCap":234368244},{"date":"2022-06-03","current":-0.306901,"twenty":-21.880488,"median":-6.941477,"eighty":-3.073299,"marketCap":225793796},{"date":"2022-06-10","current":-0.36226,"twenty":-21.681601,"median":-6.883074,"eighty":-3.05537,"marketCap":266522424},{"date":"2022-06-17","current":-0.345749,"twenty":-21.613902,"median":-6.763559,"eighty":-3.035533,"marketCap":254375289},{"date":"2022-06-24","current":-0.42733,"twenty":-21.496049,"median":-6.701289,"eighty":-3.006831,"marketCap":314396425},{"date":"2022-07-01","current":-0.415676,"twenty":-21.279781,"median":-6.501712,"eighty":-2.965947,"marketCap":305821977},{"date":"2022-07-08","current":-0.500171,"twenty":-21.193093,"median":-6.429772,"eighty":-2.934155,"marketCap":367986724},{"date":"2022-07-15","current":-0.46715,"twenty":-20.854557,"median":-6.332902,"eighty":-2.842529,"marketCap":343692455},{"date":"2022-07-22","current":-0.444812,"twenty":-20.57895,"median":-6.265778,"eighty":-2.808995,"marketCap":327258097},{"date":"2022-07-29","current":-0.393338,"twenty":-20.190331,"median":-6.213276,"eighty":-2.768913,"marketCap":289387618},{"date":"2022-08-05","current":-0.725582,"twenty":-19.934622,"median":-6.164443,"eighty":-2.70465,"marketCap":431110588},{"date":"2022-08-12","current":-0.872256,"twenty":-19.060328,"median":-6.031392,"eighty":-1.91807,"marketCap":518258166},{"date":"2022-08-19","current":-0.774906,"twenty":-18.741649,"median":-5.992391,"eighty":-1.697229,"marketCap":460416853},{"date":"2022-08-26","current":-0.769714,"twenty":-18.537884,"median":-5.917398,"eighty":-1.663044,"marketCap":457331983},{"date":"2022-09-02","current":-0.886534,"twenty":-18.187218,"median":-5.837337,"eighty":-1.603661,"marketCap":526741559},{"date":"2022-09-09","current":-0.926773,"twenty":-17.660035,"median":-5.801647,"eighty":-1.534488,"marketCap":550649302},{"date":"2022-09-16","current":-0.822932,"twenty":-17.221703,"median":-5.751196,"eighty":-1.513463,"marketCap":488951901},{"date":"2022-09-23","current":-0.729476,"twenty":-16.810619,"median":-5.716739,"eighty":-1.481204,"marketCap":433424240},{"date":"2022-09-30","current":-0.821634,"twenty":-16.602116,"median":-5.699538,"eighty":-1.469488,"marketCap":488180683},{"date":"2022-10-07","current":-0.898216,"twenty":-16.097217,"median":-5.667081,"eighty":-1.460982,"marketCap":533682516},{"date":"2022-10-14","current":-0.829422,"twenty":-15.808926,"median":-5.643842,"eighty":-1.444451,"marketCap":492807988},{"date":"2022-10-21","current":-0.776204,"twenty":-15.533592,"median":-5.608258,"eighty":-1.437228,"marketCap":461188070},{"date":"2022-10-28","current":-0.809952,"twenty":-15.441021,"median":-5.551594,"eighty":-1.424549,"marketCap":481239726},{"date":"2022-11-04","current":-0.795674,"twenty":-15.230166,"median":-5.50696,"eighty":-1.262243,"marketCap":472756333},{"date":"2022-11-11","current":-1.373728,"twenty":-15.121681,"median":-5.423859,"eighty":-1.108137,"marketCap":623483049},{"date":"2022-11-18","current":-1.275083,"twenty":-15.008957,"median":-5.380281,"eighty":-1.108137,"marketCap":578711660},{"date":"2022-11-25","current":-1.386516,"twenty":-14.862062,"median":-5.343546,"eighty":-1.108137,"marketCap":629286748},{"date":"2022-12-02","current":-1.550925,"twenty":-14.482878,"median":-5.232483,"eighty":-1.108137,"marketCap":703905730},{"date":"2022-12-09","current":-1.368248,"twenty":-14.294247,"median":-5.209253,"eighty":-1.108137,"marketCap":620995750},{"date":"2022-12-16","current":-1.40661,"twenty":-14.170417,"median":-5.174605,"eighty":-1.108137,"marketCap":638406846},{"date":"2022-12-23","current":-1.311618,"twenty":-14.076121,"median":-5.142046,"eighty":-1.108137,"marketCap":595293656},{"date":"2022-12-30","current":-1.264122,"twenty":-13.997833,"median":-5.117264,"eighty":-1.108137,"marketCap":573737061},{"date":"2023-01-06","current":-1.435838,"twenty":-13.932181,"median":-5.097174,"eighty":-1.108137,"marketCap":651672442},{"date":"2023-01-13","current":-1.441319,"twenty":-13.830214,"median":-5.070912,"eighty":-1.108137,"marketCap":654159742},{"date":"2023-01-20","current":-1.405988,"twenty":-13.781447,"median":-5.028346,"eighty":-1.086869,"marketCap":638124447},{"date":"2023-01-27","current":-1.42413,"twenty":-13.589708,"median":-5.012703,"eighty":-1.086869,"marketCap":646358311},{"date":"2023-02-03","current":-1.508035,"twenty":-13.522848,"median":-4.976725,"eighty":-1.086869,"marketCap":684439931},{"date":"2023-02-10","current":-1.342492,"twenty":-13.224591,"median":-4.94879,"eighty":-1.086869,"marketCap":609305924},{"date":"2023-02-17","current":-1.290334,"twenty":-13.11247,"median":-4.910243,"eighty":-1.086869,"marketCap":585633565},{"date":"2023-02-24","current":-1.161074,"twenty":-13.060071,"median":-4.875829,"eighty":-1.086869,"marketCap":526967285},{"date":"2023-03-03","current":-1.154271,"twenty":-12.847095,"median":-4.823426,"eighty":-1.086869,"marketCap":523879586},{"date":"2023-03-10","current":-0.94564,"twenty":-12.770987,"median":-4.802021,"eighty":-1.031058,"marketCap":429190152},{"date":"2023-03-17","current":-1.029546,"twenty":-12.720013,"median":-4.793705,"eighty":-1.009205,"marketCap":467271772},{"date":"2023-03-24","current":-1.004601,"twenty":-12.568845,"median":-4.772588,"eighty":-0.976357,"marketCap":455950210},{"date":"2023-03-31","current":-1.268887,"twenty":-12.470834,"median":-4.75551,"eighty":-0.977525,"marketCap":338257442},{"date":"2023-04-06","current":-1.224995,"twenty":-12.305176,"median":-4.745333,"eighty":-0.975189,"marketCap":326556713},{"date":"2023-04-14","current":-1.304799,"twenty":-12.16385,"median":-4.727603,"eighty":-0.974021,"marketCap":347830766},{"date":"2023-04-21","current":-1.328906,"twenty":-12.122752,"median":-4.70029,"eighty":-0.972853,"marketCap":354257048},{"date":"2023-04-28","current":-1.468581,"twenty":-11.997916,"median":-4.652411,"eighty":-0.972853,"marketCap":391491272},{"date":"2023-05-05","current":-1.712014,"twenty":-11.865439,"median":-4.619077,"eighty":-0.972853,"marketCap":456385206},{"date":"2023-05-12","current":-4.102103,"twenty":-11.6553,"median":-4.590654,"eighty":-0.972853,"marketCap":505321615},{"date":"2023-05-19","current":-3.265285,"twenty":-11.520441,"median":-4.557579,"eighty":-0.972853,"marketCap":402237363},{"date":"2023-05-26","current":-3.006135,"twenty":-11.370273,"median":-4.472309,"eighty":-0.96805,"marketCap":370313763},{"date":"2023-06-02","current":-3.057965,"twenty":-11.290634,"median":-4.416495,"eighty":-0.96805,"marketCap":376698483},{"date":"2023-06-09","current":-3.248008,"twenty":-11.160148,"median":-4.343911,"eighty":-0.96805,"marketCap":400109123},{"date":"2023-06-16","current":-3.446689,"twenty":-11.065747,"median":-4.176995,"eighty":-0.96805,"marketCap":424583883},{"date":"2023-06-23","current":-2.902475,"twenty":-10.925421,"median":-4.049331,"eighty":-0.958445,"marketCap":357544323},{"date":"2023-06-30","current":-2.781539,"twenty":-10.814096,"median":-3.92418,"eighty":-0.953642,"marketCap":342646643},{"date":"2023-07-07","current":-2.816092,"twenty":-10.781267,"median":-3.850556,"eighty":-0.953642,"marketCap":346903123},{"date":"2023-07-14","current":-2.859284,"twenty":-10.67333,"median":-3.776581,"eighty":-0.953642,"marketCap":352223723},{"date":"2023-07-21","current":-3.03205,"twenty":-10.561647,"median":-3.700048,"eighty":-0.948577,"marketCap":373506123},{"date":"2023-07-28","current":-3.222093,"twenty":-10.333498,"median":-3.602885,"eighty":-0.948577,"marketCap":396916763},{"date":"2023-08-04","current":-3.308476,"twenty":-10.180797,"median":-3.568183,"eighty":-0.948577,"marketCap":407557963},{"date":"2023-08-11","current":-3.767354,"twenty":-10.018701,"median":-3.559789,"eighty":-0.948577,"marketCap":361500257},{"date":"2023-08-18","current":-3.856523,"twenty":-9.790612,"median":-3.559789,"eighty":-0.948577,"marketCap":370056476},{"date":"2023-08-25","current":-3.967983,"twenty":-9.030371,"median":-3.559789,"eighty":-0.948577,"marketCap":380751750},{"date":"2023-09-01","current":-4.202049,"twenty":-8.925697,"median":-3.559789,"eighty":-0.948577,"marketCap":403211826},{"date":"2023-09-07","current":-4.235487,"twenty":-8.860022,"median":-3.558988,"eighty":-0.948314,"marketCap":406420408},{"date":"2023-09-15","current":-3.711624,"twenty":-8.656076,"median":-3.558422,"eighty":-0.947789,"marketCap":356152620},{"date":"2023-09-21","current":-3.510996,"twenty":-8.494674,"median":-3.555168,"eighty":-0.947527,"marketCap":336901127},{"date":"2023-09-29","current":-3.366098,"twenty":-7.885536,"median":-3.514977,"eighty":-0.947527,"marketCap":322997271},{"date":"2023-10-06","current":-3.488704,"twenty":-7.628577,"median":-3.488704,"eighty":-0.947527,"marketCap":334762073},{"date":"2023-10-12","current":-3.187761,"twenty":-7.550529,"median":-3.468404,"eighty":-0.947527,"marketCap":305884833},{"date":"2023-10-19","current":-3.198907,"twenty":-7.489292,"median":-3.43836,"eighty":-0.947527,"marketCap":306954360},{"date":"2023-10-27","current":-3.410682,"twenty":-7.364843,"median":-3.422866,"eighty":-0.946017,"marketCap":327275381},{"date":"2023-11-03","current":-3.399536,"twenty":-7.260258,"median":-3.410682,"eighty":-0.946017,"marketCap":326205853},{"date":"2023-11-10","current":-3.639863,"twenty":-7.142059,"median":-3.410682,"eighty":-0.946017,"marketCap":331835400},{"date":"2023-11-17","current":-3.64586,"twenty":-7.080352,"median":-3.410682,"eighty":-0.946017,"marketCap":332382081},{"date":"2023-11-24","current":-4.665261,"twenty":-7.012102,"median":-3.410682,"eighty":-0.946017,"marketCap":425317860},{"date":"2023-12-01","current":-4.58131,"twenty":-6.960429,"median":-3.410682,"eighty":-0.946017,"marketCap":417664326},{"date":"2023-12-08","current":-5.768613,"twenty":-6.941709,"median":-3.410682,"eighty":-0.946395,"marketCap":525907174},{"date":"2023-12-15","current":-3.957677,"twenty":-6.888179,"median":-3.406464,"eighty":-0.946395,"marketCap":360809496},{"date":"2023-12-22","current":-2.896404,"twenty":-6.765339,"median":-3.397198,"eighty":-0.946395,"marketCap":264056452},{"date":"2023-12-29","current":-2.98097,"twenty":-6.721091,"median":-3.380555,"eighty":-0.946017,"marketCap":271766129},{"date":"2024-01-05","current":-3.065537,"twenty":-6.628575,"median":-3.375132,"eighty":-0.94564,"marketCap":279475807},{"date":"2024-01-12","current":-2.917546,"twenty":-6.433232,"median":-3.370337,"eighty":-0.94564,"marketCap":265983871},{"date":"2024-01-19","current":-2.938687,"twenty":-6.370672,"median":-3.364409,"eighty":-0.944395,"marketCap":267911291},{"date":"2024-01-26","current":-2.367863,"twenty":-6.274287,"median":-3.352899,"eighty":-0.94564,"marketCap":215870968},{"date":"2024-02-02","current":-2.111415,"twenty":-6.247213,"median":-3.338703,"eighty":-0.94564,"marketCap":192491371},{"date":"2024-02-09","current":-2.219872,"twenty":-6.176835,"median":-3.327954,"eighty":-0.94564,"marketCap":202379032},{"date":"2024-02-16","current":-2.283296,"twenty":-6.051622,"median":-3.312771,"eighty":-0.94564,"marketCap":208161290},{"date":"2024-02-23","current":-2.494713,"twenty":-6.009619,"median":-3.306541,"eighty":-0.94564,"marketCap":227435484},{"date":"2024-03-01","current":-2.938687,"twenty":-5.969488,"median":-3.297936,"eighty":-0.946017,"marketCap":267911291},{"date":"2024-03-08","current":-3.065537,"twenty":-5.8937,"median":-3.287084,"eighty":-0.946017,"marketCap":279475807},{"date":"2024-03-15","current":-2.811837,"twenty":-5.809888,"median":-3.274964,"eighty":-0.946017,"marketCap":256346774},{"date":"2024-03-22","current":-3.086679,"twenty":-5.799218,"median":-3.265285,"eighty":-0.946017,"marketCap":281403226},{"date":"2024-03-28","current":-2.885833,"twenty":-5.76513,"median":-3.259954,"eighty":-0.946017,"marketCap":263092742},{"date":"2024-04-05","current":-2.600421,"twenty":-5.716739,"median":-3.246927,"eighty":-0.94564,"marketCap":237072581},{"date":"2024-04-12","current":-2.45243,"twenty":-5.699538,"median":-3.23404,"eighty":-0.94564,"marketCap":223580645},{"date":"2024-04-19","current":-2.014798,"twenty":-5.667081,"median":-3.22366,"eighty":-0.94564,"marketCap":183683065},{"date":"2024-04-26","current":-1.929174,"twenty":-5.647515,"median":-3.217872,"eighty":-0.946017,"marketCap":175877016},{"date":"2024-05-03","current":-1.909724,"twenty":-5.622076,"median":-3.204816,"eighty":-0.946017,"marketCap":174103790},{"date":"2024-05-10","current":-2.367863,"twenty":-5.556424,"median":-3.191843,"eighty":-0.946017,"marketCap":215870968},{"date":"2024-05-17","current":-2.219872,"twenty":-5.519932,"median":-3.178902,"eighty":-0.946017,"marketCap":202379032},{"date":"2024-05-24","current":-2.049047,"twenty":-5.440885,"median":-3.152987,"eighty":-0.946017,"marketCap":186805484},{"date":"2024-05-31","current":-2.780497,"twenty":-5.391835,"median":-3.13571,"eighty":-0.946017,"marketCap":174123050},{"date":"2024-06-07","current":-2.785421,"twenty":-5.359835,"median":-3.120885,"eighty":-0.946017,"marketCap":174431437},{"date":"2024-06-14","current":-2.95347,"twenty":-5.239213,"median":-3.10782,"eighty":-0.946017,"marketCap":184955146},{"date":"2024-06-21","current":-2.767262,"twenty":-5.222315,"median":-3.078974,"eighty":-0.94564,"marketCap":173294260},{"date":"2024-06-28","current":-3.029184,"twenty":-5.188683,"median":-3.068958,"eighty":-0.94564,"marketCap":189696597},{"date":"2024-07-05","current":-2.841745,"twenty":-5.159744,"median":-3.065537,"eighty":-0.94564,"marketCap":177958614},{"date":"2024-07-12","current":-3.754933,"twenty":-5.137417,"median":-3.065537,"eighty":-0.94564,"marketCap":235145142},{"date":"2024-07-19","current":-3.231704,"twenty":-5.115197,"median":-3.065537,"eighty":-0.94564,"marketCap":202379016},{"date":"2024-07-26","current":-3.754933,"twenty":-5.094154,"median":-3.065537,"eighty":-0.94564,"marketCap":235145142},{"date":"2024-08-02","current":-3.416373,"twenty":-5.04698,"median":-3.065537,"eighty":-0.94564,"marketCap":213943531},{"date":"2024-08-09","current":-3.065195,"twenty":-5.024435,"median":-3.05695,"eighty":-0.94564,"marketCap":191951678},{"date":"2024-08-16","current":-2.182478,"twenty":-5.000189,"median":-3.049315,"eighty":-0.94564,"marketCap":136673295},{"date":"2024-08-23","current":-2.11969,"twenty":-4.971529,"median":-3.036846,"eighty":-0.94564,"marketCap":132741360},{"date":"2024-08-30","current":-1.728192,"twenty":-4.935272,"median":-3.030232,"eighty":-0.94564,"marketCap":108224588},{"date":"2024-09-06","current":-1.627856,"twenty":-4.886775,"median":-3.023316,"eighty":-0.94564,"marketCap":101941201},{"date":"2024-09-13","current":-0.390733,"twenty":-4.849566,"median":-3.001952,"eighty":-0.939415,"marketCap":117472846},{"date":"2024-09-20","current":-0.303273,"twenty":-4.817525,"median":-2.981205,"eighty":-0.922879,"marketCap":91178165},{"date":"2024-09-27","current":-0.306373,"twenty":-4.800463,"median":-2.965003,"eighty":-0.906004,"marketCap":97810009},{"date":"2024-10-04","current":-0.346219,"twenty":-4.774152,"median":-2.957874,"eighty":-0.890428,"marketCap":110530740},{"date":"2024-10-11","current":-0.307345,"twenty":-4.761712,"median":-2.944543,"eighty":-0.885062,"marketCap":98120271},{"date":"2024-10-18","current":-0.298113,"twenty":-4.747559,"median":-2.938687,"eighty":-0.873704,"marketCap":95172785},{"date":"2024-10-25","current":-0.291674,"twenty":-4.728637,"median":-2.919837,"eighty":-0.868837,"marketCap":93117301},{"date":"2024-11-01","current":-0.283049,"twenty":-4.70073,"median":-2.910332,"eighty":-0.861536,"marketCap":90363728},{"date":"2024-11-08","current":-0.246423,"twenty":-4.665261,"median":-2.896404,"eighty":-0.854084,"marketCap":78670739},{"date":"2024-11-15","current":-0.213021,"twenty":-4.640783,"median":-2.891352,"eighty":-0.83801,"marketCap":62377744},{"date":"2024-11-22","current":-0.232477,"twenty":-4.605296,"median":-2.877928,"eighty":-0.822932,"marketCap":68074963},{"date":"2024-11-29","current":-0.268932,"twenty":-4.594271,"median":-2.864981,"eighty":-0.819038,"marketCap":78749957},{"date":"2024-12-06","current":-0.302266,"twenty":-4.58131,"median":-2.841438,"eighty":-0.813846,"marketCap":88511063},{"date":"2024-12-13","current":-0.210497,"twenty":-4.553962,"median":-2.815377,"eighty":-0.809952,"marketCap":61638855},{"date":"2024-12-20","current":-0.282212,"twenty":-4.451637,"median":-2.808453,"eighty":-0.800866,"marketCap":82638844},{"date":"2024-12-27","current":-0.291509,"twenty":-4.404092,"median":-2.791444,"eighty":-0.795014,"marketCap":85361065},{"date":"2025-01-03","current":-0.304789,"twenty":-4.358093,"median":-2.782253,"eighty":-0.776204,"marketCap":89249952},{"date":"2025-01-10","current":-0.280884,"twenty":-4.262828,"median":-2.774341,"eighty":-0.774084,"marketCap":82249955},{"date":"2025-01-17","current":-0.277232,"twenty":-4.202049,"median":-2.723315,"eighty":-0.769195,"marketCap":81180511},{"date":"2025-01-24","current":-0.258971,"twenty":-4.157761,"median":-2.706129,"eighty":-0.762889,"marketCap":75833292},{"date":"2025-01-31","current":-0.257311,"twenty":-4.101694,"median":-2.663846,"eighty":-0.748946,"marketCap":75347181},{"date":"2025-02-07","current":-0.208837,"twenty":-4.000796,"median":-2.600421,"eighty":-0.728955,"marketCap":61152744},{"date":"2025-02-14","current":-0.241375,"twenty":-3.967983,"median":-2.494713,"eighty":-0.708052,"marketCap":70680517},{"date":"2025-02-21","current":-0.135722,"twenty":-3.945685,"median":-2.45243,"eighty":-0.641365,"marketCap":39742847},{"date":"2025-02-28","current":-0.135722,"twenty":-3.915909,"median":-2.32558,"eighty":-0.622869,"marketCap":39742847},{"date":"2025-03-07","current":-0.133071,"twenty":-3.869162,"median":-2.262155,"eighty":-0.591231,"marketCap":38966628},{"date":"2025-03-14","current":-0.124754,"twenty":-3.857725,"median":-2.219872,"eighty":-0.56154,"marketCap":36531213},{"date":"2025-03-21","current":-0.129745,"twenty":-3.857725,"median":-2.177588,"eighty":-0.530388,"marketCap":37992462},{"date":"2025-03-28","current":-0.165937,"twenty":-3.857725,"median":-2.156447,"eighty":-0.500534,"marketCap":39943485},{"date":"2025-04-04","current":-0.20132,"twenty":-3.857725,"median":-2.132422,"eighty":-0.493584,"marketCap":48460846},{"date":"2025-04-11","current":-0.209455,"twenty":-3.857124,"median":-2.107187,"eighty":-0.485214,"marketCap":50418860},{"date":"2025-04-17","current":-0.168377,"twenty":-3.857124,"median":-2.079491,"eighty":-0.46939,"marketCap":40530889},{"date":"2025-04-25","current":-0.16919,"twenty":-3.813758,"median":-2.037505,"eighty":-0.454884,"marketCap":40726691},{"date":"2025-05-02","current":-0.16065,"twenty":-3.784139,"median":-1.99575,"eighty":-0.444812,"marketCap":38670776},{"date":"2025-05-09","current":-0.142348,"twenty":-3.754933,"median":-1.951055,"eighty":-0.437469,"marketCap":34265245},{"date":"2025-05-16","current":-0.243367,"twenty":-3.720541,"median":-1.920405,"eighty":-0.434156,"marketCap":48668516},{"date":"2025-05-23","current":-0.244346,"twenty":-3.678068,"median":-1.877031,"eighty":-0.43032,"marketCap":48864365},{"date":"2025-05-30","current":-0.243367,"twenty":-3.642262,"median":-1.780463,"eighty":-0.422755,"marketCap":48668516}],"updateTime":1760664427641},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BLUE\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2540244798","title":"Press Release: bluebird bio Announces Completion of Acquisition by Carlyle and SK Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2540244798","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540244798?lang=en_us&edition=fundamental","pubTime":"2025-06-02 20:34","pubTimestamp":1748867640,"startTime":"0","endTime":"0","summary":"New management, led by David Meek, is committed to rapidly scaling access to lifechanging gene therapies. Significant capital commitment from Carlyle and SK Capital will enable bluebird to grow and accelerate patient access. bluebird will focus on expanding manufacturing capacity and improving the treatment experience for patients and providers. David Meek, who became Chief Executive Officer of bluebird at close, said, \"Today marks the beginning of a new era for bluebird as its go-forward financial backing and leadership team will better enable all stakeholders to realize the full potential of our revolutionary therapies. Historically, bluebird has excelled as a scientific innovator and should be very proud of the many achievements it has delivered to patients. Our vision is to further that legacy of scientific excellence while improving the commercial execution of our approved products to rapidly expand access to lifechanging gene therapies.\". The company's momentum is reinforced by a","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLUE","BK4135","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","BK4556","BK4578","IE00BGHQF748.EUR","BK4139","CG"],"gpt_icon":0},{"id":"2539222635","title":"Press Release: Carlyle and SK Capital Partners Announce Expiration of bluebird bio Tender Offer","url":"https://stock-news.laohu8.com/highlight/detail?id=2539222635","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2539222635?lang=en_us&edition=fundamental","pubTime":"2025-05-30 20:30","pubTimestamp":1748608200,"startTime":"0","endTime":"0","summary":"All conditions of the Offer have been satisfied and the parties expect to consummate the acquisition on June 2, 2025. Founded in 2010, bluebird has been setting the standard for gene therapy for more than a decade--first as a scientific pioneer and now as a commercial leader. bluebird has an unrivaled track record in bringing the promise of gene therapy out of clinical studies and into the real-world setting, having secured FDA approvals for three therapies in under two years. Today, we are proving and scaling the commercial model for gene therapy and delivering innovative solutions for access to patients, providers, and payers.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","CG","BK4556","BK4139","BK4578","BLUE","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","BK4135"],"gpt_icon":0},{"id":"2538049348","title":"Gene Therapy Death Worsens Picture for an Already Troubled Field -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2538049348","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538049348?lang=en_us&edition=fundamental","pubTime":"2025-05-28 00:11","pubTimestamp":1748362260,"startTime":"0","endTime":"0","summary":"The death of a patient in a trial of an experimental gene therapy casts new shadows over a technology once seen as the future of the drug industry.Rocket Pharmaceuticals, a New Jersey-based biotech, said early Tuesday that a patient participating in a small trial of a gene therapy died over the weekend. The therapy is meant to treat a rare genetic condition called Danon Disease, which weakens the heart muscle and generally kills male patients in early adulthood. Rocket shares fell 58.6% on Tuesday.The gene therapy, called RP-A501, was being tested in a Phase 2 trial -- the last step before Rocket planned to submit the treatment for Food and Drug Administration approval. Analysts had been reasonably confident that the trial would be successful: In February, Jefferies analysts Andrew Tsai wrote that he put 65% to 75% odds on a positive readout.Or take Pfizer, which in 2019 unveiled plans to invest hundreds of millions of dollars in a \"state-of-the-art gene therapy manufacturing f","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","RCKT","LU0211331839.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","BK4532","IE0002141913.USD","LU0320765489.SGD","BK4585","NVS","SRPT","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU0208291251.USD","BK4578","BK4588","BK4007","LU0070302665.USD","BK4139","IE00BJT1NW94.SGD","BLUE","BK4556"],"gpt_icon":1},{"id":"2538660334","title":"Bluebird Bio Urges Stockholders to Tender Shares as Carlyle and SK Capital Acquisition Deadline Approaches","url":"https://stock-news.laohu8.com/highlight/detail?id=2538660334","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538660334?lang=en_us&edition=fundamental","pubTime":"2025-05-27 20:30","pubTimestamp":1748349023,"startTime":"0","endTime":"0","summary":"Bluebird Bio Inc. has announced an update to its merger and acquisition transaction with Carlyle and SK Capital. The company has amended its agreement, providing stockholders with the option to receive either the original offer of $3.00 per share in cash plus a contingent value right of $6.84 per share in cash, contingent on achieving a net sales milestone, or a revised offer of $5.00 per share in cash. The transaction has received all necessary regulatory approvals and is expected to be finalized shortly after the tender offer deadline, which is set for May 29, 2025. Ayrmid Ltd. has confirmed it will not submit a competing proposal, solidifying the transaction with Carlyle and SK Capital as the sole option for Bluebird stockholders.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpret","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250527:nNDL2pX4sg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4578","BLUE","BK4556","BK4139"],"gpt_icon":0},{"id":"2536323835","title":"BRIEF-Carlyle, SK Capital Partners And Bluebird Bio Provide Updated Tender Instructions","url":"https://stock-news.laohu8.com/highlight/detail?id=2536323835","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536323835?lang=en_us&edition=fundamental","pubTime":"2025-05-17 04:43","pubTimestamp":1747428186,"startTime":"0","endTime":"0","summary":"BRIEF-Carlyle, SK Capital Partners And Bluebird Bio Provide Updated Tender InstructionsMay 16 (Reuters) - CARLYLE, SK CAPITAL PARTNERS AND BLUEBIRD BIO PROVIDE UPDATED TENDER INSTRUCTIONSCARLYLE: BLUE","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250516:nTUA1DVXVV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CG","IE00BGHQF748.EUR","BK4578","BK4556","IE00B3QW5Z07.USD","BK4135","BK4139","BLUE","IE00B64PRP62.GBP"],"gpt_icon":0},{"id":"2536532898","title":"Press Release: Carlyle, SK Capital Partners and bluebird bio Provide Updated Tender Instructions","url":"https://stock-news.laohu8.com/highlight/detail?id=2536532898","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536532898?lang=en_us&edition=fundamental","pubTime":"2025-05-17 04:30","pubTimestamp":1747427400,"startTime":"0","endTime":"0","summary":"Stockholders that have previously tendered their shares must re-tender their shares. Stockholders may elect to receive either $3.00 per share plus CVR of $6.84 per share in cash payable upon achievement of a net sales milestone or $5.00 per share with no CVR. As previously announced on May 14, 2025, Carlyle  , SK Capital Partners, LP  and bluebird bio, Inc.  , have amended their definitive agreement pursuant to which Carlyle and SK Capital will purchase all of the outstanding shares of bluebird. The parties have issued the following updated instructions for stockholders to tender their shares into the offer.tendered their shares must re-tender their shares and complete and sign. The bluebird board of directors unanimously approved the amended agreement and recommends that all stockholders immediately tender their shares in support of the transaction. The bluebird board of directors continues to believe that the transaction with Carlyle and SK Capital, as amended, represents the only vi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4556","CG","BK4578","IE00BGHQF748.EUR","BLUE","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","BK4135","BK4139"],"gpt_icon":0},{"id":"2535885538","title":"Deals of the day-Mergers and acquisitions","url":"https://stock-news.laohu8.com/highlight/detail?id=2535885538","media":"Reuters","labels":["merge","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535885538?lang=en_us&edition=fundamental","pubTime":"2025-05-15 04:46","pubTimestamp":1747255600,"startTime":"0","endTime":"0","summary":"Deals of the day-Mergers and acquisitionsAdds Aeva Technologies, Carlyle Group, TenneT and AceaMay 14 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 2039 GMT on W","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nL4N3RM1QZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0985481810.HKD","LU0345769631.USD","ACV.SI","LU0456855351.SGD","LU0058720904.USD","IE00BLSP4452.SGD","LU0971552830.HKD","LU1868837136.USD","IFL.AU","IE00BJJMRY28.SGD","IE000KEQY171.SGD","LU0096364046.USD","HK0000306701.USD","SG9999014559.SGD","BLUE","LU2237443549.SGD","LU1934455863.HKD","LU2237443895.HKD","IE00B19Z8W00.USD","LU1670756490.USD","LU2106854487.HKD","LU2168564065.EUR","LU2168564149.EUR","MACW.SI","HK0000320264.USD","HK0000306685.HKD","BK4527","GSK.UK","LU0354030511.USD","LU0724617625.USD","LU0788109477.HKD","LU2456880835.USD","LU0314104364.USD","LU2092937148.SGD","LU1814569148.SGD","LU2065171311.SGD","LU0965509010.AUD","AEVA","CG","SG9999014906.USD","LU2097344357.USD","ALG","LU2133065610.SGD","LU0323591593.USD","LU1145028129.USD","LU1116320737.USD","LU1815333072.USD","SG9999018865.SGD","TQ5.SI"],"gpt_icon":1},{"id":"2535045005","title":"BUZZ-U.S. STOCKS ON THE MOVE-Robinhood, Oklo, Chimera Investment","url":"https://stock-news.laohu8.com/highlight/detail?id=2535045005","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535045005?lang=en_us&edition=fundamental","pubTime":"2025-05-15 01:55","pubTimestamp":1747245319,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Robinhood, Oklo, Chimera InvestmentEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nL6N3RM0OJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CIM","NEXT","NVDS.UK","NXT","CG","NFE","SNVD.UK","PVH","NVD2.UK","2NVD.UK","NVDU","SPRU","HOOD","NVDD","TXO","HTZ","EWCZ","MRP","RTX","NVD","3NVD.UK","MESA","MP","AEO","LOAR","GPI","GRAL","KKR","BLUE","MAGN","ANTA","ABBV","AUR","NEM","JCI","FRGE","SRE","NVIW.SI","LEGN","OKLO","SEPN","EXEL"],"gpt_icon":1},{"id":"2535272490","title":"Bluebird bio, Carlyle, SK Capital Revise Acquisition Deal to Add New Cash Option","url":"https://stock-news.laohu8.com/highlight/detail?id=2535272490","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535272490?lang=en_us&edition=fundamental","pubTime":"2025-05-14 21:32","pubTimestamp":1747229524,"startTime":"0","endTime":"0","summary":"Bluebird bio , Carlyle  and SK Capital Partners said Wednesday they have amended their Bluebird acquisition agreement to give shareholders a new cash option of $5 a share.Under the revised terms, shareholders can now choose either $5 a share in cash or keep the original structure of $3 a share in cash plus a $6.84 per share contingent value right, or CVR, tied to future net sales, the companies said. Shares tendered without a selection will receive the original offer with the CVR, they said.According to the joint statement, Bluebird's board has approved the revised deal and urged shareholders to tender their shares, adding that the inability to reach majority support could lead to default on loan agreements and leave shareholders with no recovery in a possible bankruptcy.The tender deadline has been extended to May 29, the companies said, adding that as of May 13, about 2.3 million shares had been tendered.Bluebird shares were up more than 50% in early trading, while Carlyle's stock wa","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4578","CG","BK4556","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","BK4139","IE00B64PRP62.GBP","BLUE","BK4135"],"gpt_icon":0},{"id":"2535022443","title":"BUZZ- bluebird bio soars on revised offer from Carlyle, SK Capital Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2535022443","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535022443?lang=en_us&edition=fundamental","pubTime":"2025-05-14 21:18","pubTimestamp":1747228734,"startTime":"0","endTime":"0","summary":"BUZZ-bluebird bio soars on revised offer from Carlyle, SK Capital Partners** Shares of gene therapy maker bluebird bio BLUE.O rise 50.5% to $4.98 premarket ** Bluebird bio says its board approved the revised merger deal with investment firms Carlyle CG.O and SK Capital Partners** Under terms of the amended deal, bluebird stockholders can elect to get $5 per share in cash or the original offer of $3 per share in cash plus a contingent value right of $6.84 per share that is payable upon achievement of a net sales milestone** New offer price of $5 represents a 51% premium to BLUE's last closing price ** \"The amended offer price provides an alternative for stockholders who would prefer greater upfront cash consideration instead of the potential upside of the CVR\", the cos say ** Up to last close, stock down 60.3% YTD   ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nL6N3RM0OL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CG","BK4556","IE00B3QW5Z07.USD","BK4139","IE00B64PRP62.GBP","BK4135","IE00BGHQF748.EUR","BK4578","BLUE"],"gpt_icon":0},{"id":"2535202155","title":"Bluebird bio receives higher upfront offer from PE firms Carlyle, SK Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2535202155","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535202155?lang=en_us&edition=fundamental","pubTime":"2025-05-14 20:41","pubTimestamp":1747226473,"startTime":"0","endTime":"0","summary":"Bluebird bio receives higher upfront offer from PE firms Carlyle, SK Capital May 14  - Bluebird bio BLUE.O and Carlyle Group CG.O and SK Capital Partners said on Wednesday that the private equity firms have offered $5 per share upfront to takeover the gene therapy maker.Shareholders may elect to receive either the new offer or the previous offer of $3 per share, with an additional $6.84 contingent upon bluebird achieving certain sales milestones.  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nL4N3RM14X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00B3QW5Z07.USD","BK4556","BK4578","BK4135","IE00B64PRP62.GBP","IE00BGHQF748.EUR","BLUE","CG"],"gpt_icon":0},{"id":"2535216700","title":"BRIEF-Carlyle says Bluebird stockholders can elect $3 per share plus cvr or $5 per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2535216700","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535216700?lang=en_us&edition=fundamental","pubTime":"2025-05-14 20:39","pubTimestamp":1747226385,"startTime":"0","endTime":"0","summary":"BRIEF-Carlyle says Bluebird stockholders can elect $3 per share plus cvr or $5 per share May 14  - Carlyle Group CG.O:CARLYLE- BLUEBIRD STOCKHOLDERS CAN ELECT $3 PER SHARE PLUS CVR OR $5 PER SHARE CARLYLE, SK CAPITAL PARTNERS AND BLUEBIRD BIO AMEND MERGER AGREEMENT ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250514:nL8N3RM1BM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CG","IE00BGHQF748.EUR","BK4578","BK4556","IE00B3QW5Z07.USD","BK4135","BK4139","BLUE","IE00B64PRP62.GBP"],"gpt_icon":0},{"id":"2535502975","title":"Press Release: Carlyle, SK Capital Partners and bluebird bio Amend Merger Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2535502975","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535502975?lang=en_us&edition=fundamental","pubTime":"2025-05-14 20:30","pubTimestamp":1747225800,"startTime":"0","endTime":"0","summary":"Stockholders may elect to receive either $3.00 per share plus CVR of $6.84 per share in cash payable upon achievement of a net sales milestone or $5.00 per share with no CVR. The bluebird board of directors unanimously approved the amended agreement and recommends that all stockholders immediately tender their shares in support of the transaction. The bluebird board of directors continues to believe that the transaction with Carlyle and SK Capital, as amended, represents the only viable option for stockholders to receive consideration for their shares. Absent a majority of stockholders tendering, bluebird is at significant risk of defaulting on its loan agreements with Hercules Capital, and it is extremely unlikely that stockholders would receive any consideration for their shares in a bankruptcy or liquidation.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","CG","IE00BGHQF748.EUR","BK4135","BK4139","IE00B64PRP62.GBP","BK4556","BK4578","BLUE"],"gpt_icon":0},{"id":"2534583489","title":"Press Release: Important Information for bluebird bio Stockholders to Tender Shares for Acquisition by Carlyle and SK Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2534583489","media":"Dow Jones","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534583489?lang=en_us&edition=fundamental","pubTime":"2025-05-09 20:30","pubTimestamp":1746793800,"startTime":"0","endTime":"0","summary":"Important Information for bluebird bio Stockholders to Tender Shares for Acquisition by Carlyle and SK Capital. bluebird bio, Inc.   today reminds all stockholders, including individual stockholders, to promptly tender their shares into the tender offer by Carlyle and SK Capital to purchase all outstanding shares of bluebird common stock by 11:59 p.m. Eastern on May 12, 2025.Stockholders that hold shares of bluebird common stock through a broker or other nominee may be subject to a processing cutoff that is prior to the tender deadline, so it is important to act now.Every share tendered by stockholders is important and it is important to tender now. If a majority of the outstanding shares of bluebird common stock are not tendered, the tender offer will not be completed, and bluebird will not be acquired, putting bluebird at significant risk of defaulting on its loan agreements with Hercules Capital and being forced into bankruptcy or liquidation. It is extremely unlikely that stockhold","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4556","BK4139","III","BLUE","BK4578","BK4134"],"gpt_icon":0},{"id":"2533572418","title":"Bluebird bio, Carlyle-SK Deal Clears Regulatory Hurdles","url":"https://stock-news.laohu8.com/highlight/detail?id=2533572418","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533572418?lang=en_us&edition=fundamental","pubTime":"2025-05-06 17:07","pubTimestamp":1746522476,"startTime":"0","endTime":"0","summary":"Bluebird bio , Carlyle , SK Capital Partners and Beacon Parent said late Monday that all required regulatory approvals have been received for the Bluebird bio's acquisition by Carlyle and SK Capital.The companies said no additional approvals are needed, and the merger is expected to close soon on May 12.Under the deal, Bluebird bio's shareholders will receive $3 per share in cash upfront and a contingent value right worth up to $6.84 per share, based on future sales milestones, bringing the total potential value to $9.84 per share.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BLUE","BK4556","BK4578","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","CG","BK4135","IE00BGHQF748.EUR","BK4139"],"gpt_icon":0},{"id":"2533056806","title":"BRIEF-Carlyle And Sk Capital Receive All Required Regulatory Approvals To Complete The Acquisition Of Bluebird Bio","url":"https://stock-news.laohu8.com/highlight/detail?id=2533056806","media":"Reuters","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533056806?lang=en_us&edition=fundamental","pubTime":"2025-05-06 04:26","pubTimestamp":1746476784,"startTime":"0","endTime":"0","summary":"BRIEF-Carlyle And Sk Capital Receive All Required Regulatory Approvals To Complete The Acquisition Of Bluebird Biobluebird bio Inc BLUE.O:CARLYLE AND SK CAPITAL RECEIVE ALL REQUIRED REGULATORY APPROVA","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nTUA2WCCQB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","BK4135","BK4556","CG","IE00B64PRP62.GBP","BK4139","IE00BGHQF748.EUR","BK4578","BLUE"],"gpt_icon":0},{"id":"2533917584","title":"bluebird bio Inc  expected to post a loss of $3.69 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2533917584","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533917584?lang=en_us&edition=fundamental","pubTime":"2025-05-05 21:07","pubTimestamp":1746450425,"startTime":"0","endTime":"0","summary":"bluebird bio Inc  expected to post a loss of $3.69 a share - Earnings Preview bluebird bio Inc BLUE.OQ BLUE.O is expected to show a rise in quarterly revenue when it reports  results on May 7 (estimat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nL8N3RD14K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLUE"],"gpt_icon":0},{"id":"2530643321","title":"US Health Secretary Reportedly Says 35 States to Join Pilot Program for Sickle Cell Disease Gene Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2530643321","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2530643321?lang=en_us&edition=fundamental","pubTime":"2025-04-26 03:19","pubTimestamp":1745608779,"startTime":"0","endTime":"0","summary":"US Health and Human Services Secretary Robert Kennedy Jr. said 35 states will participate in a federal pilot program to expand access of costly gene therapies for sickle cell disease to Medicaid patients, multiple news outlets reported Friday.These 35 states house almost 84% of the Medicaid patients with the genetic blood disorder, Bloomberg reported, citing Kennedy's speech to the National Council of Insurance Legislators.The pilot program would also allow the Centers for Medicare and Medicaid Services to arrange payment agreements for the therapies on behalf of states, Bloomberg said.The various states' interest in the pilot program represents \"positive news\" for pharmaceutical companies that manufacture the gene therapies, including Bluebird Bio , Vertex Pharmaceuticals  and Crispr Therapeutics . The companies' therapies, which were approved in December 2023, come with a costly price tag and \"have struggled to gain traction,\" according to Bloomberg.The Department of Health and Human","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0109394709.USD","BLUE","IE00B19Z3581.USD","IE00B19Z9Z06.USD","BK4585","LU0058720904.USD","LU0234570918.USD","LU1035775433.USD","IE00BZ9MQY76.HKD","LU0320765992.SGD","LU1430594728.SGD","LU1093756325.SGD","SGXZ57979304.SGD","BK4556","LU2324357040.USD","IE00B4R5TH58.HKD","BK4578","LU0417517546.SGD","LU0823416689.USD","IE00B2B36J28.USD","LU1861559042.SGD","LU1585245621.USD","BK4139","LU2417539215.USD","LU2456880835.USD","LU2462157665.USD","LU0061475181.USD","SG9999013999.USD","BK4567","LU0256863811.USD","BK4611","IE00B19Z3B42.SGD","LU2362541273.HKD","IE00BJT1NW94.SGD","LU0889565916.HKD","CRSP","IE00BFTCPJ56.SGD","IE0002270589.USD","IE00B894F039.SGD","BK4533","IE0002141913.USD","LU1861558580.USD","LU1093756168.USD","SG9999001176.SGD","IE00B19Z9P08.USD","VRTX","LU2237438978.USD","LU2236285917.USD","LU0079474960.USD","LU0289739699.SGD"],"gpt_icon":0},{"id":"2528527322","title":"BUZZ-U.S. STOCKS ON THE MOVE-Grocery Outlet, Abbott, General Dynamics","url":"https://stock-news.laohu8.com/highlight/detail?id=2528527322","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528527322?lang=en_us&edition=fundamental","pubTime":"2025-04-17 02:02","pubTimestamp":1744826527,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Grocery Outlet, Abbott, General DynamicsEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250416:nL6N3QU0QE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GO","RGLD","OMC","CFG","CALM","FANG","AREC","GD","KKR","UAL","NVIW.SI","ICAD","LYFT","OST","NOVA","CYD","MPC","FRGE","XOM","URGN","NEE","NVDY","DVN","SIVBQ","03888","ALV","APA","NEM","CVX","HWC","MOV","TRV","HTZ","BLUE","CLIK","SNVD.UK","ABT","JBHT","PLD","TGL"],"gpt_icon":1},{"id":"2527407812","title":"Bluebird Bio Reaffirms Support for Carlyle Deal Amid Lack of Binding Offer From Ayrmid","url":"https://stock-news.laohu8.com/highlight/detail?id=2527407812","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527407812?lang=en_us&edition=fundamental","pubTime":"2025-04-16 22:58","pubTimestamp":1744815503,"startTime":"0","endTime":"0","summary":"Bluebird Bio  said Wednesday its board reaffirmed its support for its planned acquisition by Carlyle  and SK Capital as Ayrmid has not sent a binding or fully financed offer after three weeks of engagement, including a timeline extension.Bluebird said Ayrmid's proposal remained \"highly conditional\" even after it engaged with Ayrmid on two occasions.The company said it has recommended that all stockholders tender by May 2 into the current agreement with Carlyle and SK Capital.Under the deal announced in February, Bluebird agreed to be acquired and taken private by funds managed by Carlyle and SK Capital for $3 a share in cash and a one-time contingent value right of $6.84 a share payable upon achieving a net sales milestone.Shares of Bluebird were down more than 6% in recent trading Wednesday.Price: 4.19, Change: -0.28, Percent Change: -6.26","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CG","BK4578","BLUE","IE00B3QW5Z07.USD","BK4139","BK4135","IE00BGHQF748.EUR","IE00B64PRP62.GBP","BK4556"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":22,"code":"91000000","status":"200"}]}}